Clinical Trials Browser

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

NCT00288119 2025-07-18

FBE

Recruiting

2,000 enrolled

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT06746623 2025-06-05

Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux

Phase NA Recruiting

400 enrolled

Gastrointestinal

Barrett Esophagus, Tobacco Use

NCT02198976 2025-03-27

ABCDE

Recruiting

300 enrolled

Gastrointestinal

Barrett Esophagus

NCT02634645 2025-02-28

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

Recruiting

5,000 enrolled

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT00590239 2024-11-22

BERN

Recruiting

150 enrolled

Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux, Neoplasms

NCT06693622 2024-11-18

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Recruiting

556 enrolled

Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT03222635 2024-07-24

PREFER

Phase NA Recruiting

225 enrolled

Gastrointestinal

Barrett Esophagus

NCT05530343 2024-06-12

SWAT-BE

Phase NA Recruiting

2,298 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT04155242 2024-05-08

PROBAN

Phase NA Recruiting

147 enrolled

Gastrointestinal

Barrett Esophagus

NCT04867590 2024-04-09

ENDOBARRETT

Phase NA Recruiting

140 enrolled

Gastrointestinal

Barrett Esophagus

NCT05818072 2023-05-11

The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

Phase NA Recruiting

165 enrolled

Gastrointestinal

Barrett Esophagus

NCT00574327 2023-03-16

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

Recruiting

3,000 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Gastroesophageal Reflux

NCT05642338 2022-12-08

WATSEURO2

Recruiting

416 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus, Disease

Clinical Trials

Obeticholic Acid for Prevention in Barrett's Esophagus

Longitudinal Oral Microbiome Sampling for BE

SLURP

DS-MCE-BE

Impact of RFA on Esophageal Distensibility and Mucosal Impedance

Clinical Utility of WATS3D: A 5-Year Prospective Study

DETECT-ME

Endeavor-1

MAGEC

ESD

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

EsophaCap for the Detection of Early Esophageal Carcinoma

SOS4C

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

SURVENT

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System

IVLCM

BLISS

ULSBE

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

FBE

Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux

ABCDE

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

BERN

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

PREFER

SWAT-BE

PROBAN

ENDOBARRETT

The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

WATSEURO2